Skip to main content

Veopoz Side Effects

Generic name: pozelimab

Medically reviewed by Drugs.com. Last updated on Jun 13, 2023.

Note: This document contains side effect information about pozelimab. Some dosage forms listed on this page may not apply to the brand name Veopoz.

Applies to pozelimab: injectable solution.

Warning

You may get infections more easily, even serious or fatal infections. Call your doctor if you have flu symptoms, cough, night sweats, headache, neck stiffness, increased sensitivity to light, confusion, or vision problems.

Make sure you are current on all vaccines before you start using pozelimab. Talk to your doctor if you are not current on your vaccines.

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Read the Patient Wallet Card about the symptoms of meningococcal or other infections and learn what symptoms to watch for. Keep the card with you at all times.

You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to pozelimab: injectable solution.

General

Most common adverse reactions were upper respiratory tract infection, fracture, urticaria, and alopecia.[Ref]

Cardiovascular

Frequency not reported: Elevated systolic blood pressure, elevated diastolic blood pressure[Ref]

Dermatologic

Very common (10% or more): Urticaria (20%), alopecia (20%)[Ref]

Gastrointestinal

Frequency not reported: Gingival bleeding[Ref]

Hypersensitivity

Frequency not reported: Systemic hypersensitivity reactions, immune complex formation[Ref]

Local

Frequency not reported: Injection site reactions (included dermatitis and erythema)[Ref]

Metabolic

Frequency not reported: Metabolic acidosis, increased blood uric acid[Ref]

Musculoskeletal

Very common (10% or more): Fracture (30%)[Ref]

Nervous system

Frequency not reported: Serious meningococcal infections[Ref]

Other

Frequency not reported: Bacterial infections[Ref]

Respiratory

Very common (10% or more): Upper respiratory tract infection (30%)[Ref]

Genitourinary

Frequency not reported: Hematuria, proteinuria[Ref]

Hepatic

Frequency not reported: Increased liver enzymes[Ref]

References

1. Product Information. Veopoz (pozelimab). Regeneron Pharmaceuticals Inc. 2023;ORIG-1.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.